1 – 38 of 38
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Exertional breathlessness related to medical conditions in middle-aged people : the population-based SCAPIS study of more than 25,000 men and women
(
- Contribution to journal › Article
-
Mark
Risk of lung disease in the PI*SS genotype of alpha-1 antitrypsin : an EARCO research project
(
- Contribution to journal › Article
- 2023
-
Mark
High prevalence of interstitial lung abnormalities in middle-aged never-smokers
(
- Contribution to journal › Article
-
Mark
Characteristics of individuals with alpha-1 antitrypsin deficiency from Northern and Southern European countries : EARCO international registry
(
- Contribution to journal › Letter
- 2022
-
Mark
Triglyceride-Glucose Index is a Risk Marker of Incident COPD Events in Women
(
- Contribution to journal › Article
-
Mark
The Clinical Course of Severe Alpha-1-Antitrypsin Deficiency in Patients Identified by Screening
(
- Contribution to journal › Article
-
Mark
Impact of COVID-19 in Patients With Severe Alpha-1 Antitrypsin Deficiency : The IMCA1 Study of the EARCO Clinical Research Collaboration
(
- Contribution to journal › Letter
-
Mark
Cancer risk in severe alpha-1-antitrypsin deficiency: the importance of early identification
(
- Contribution to journal › Article
-
Mark
Low Prevalence of Mild Alpha-1-Antitrypsin Deficiency in Hospitalized COVID-19-Patients
(
- Contribution to journal › Article
-
Mark
Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency : EARCO international registry
(
- Contribution to journal › Article
-
Mark
Cancer risk in severe alpha-1-antitrypsin deficiency
(
- Contribution to journal › Article
- 2021
-
Mark
Advanced dental cleaning is associated with reduced risk of copd exacerbations – a randomized controlled trial
(
- Contribution to journal › Article
-
Mark
Lung Function and Health Status in Individuals with Severe Alpha-1-Antitrypsin Deficiency at the Age of 42
(
- Contribution to journal › Article
-
Mark
Severe alpha-1-antitrypsin deficiency increases the risk of venous thromboembolism
(
- Contribution to journal › Article
-
Mark
The ratio FEV1/FVC and its association to respiratory symptoms—A Swedish general population study
(
- Contribution to journal › Article
- 2020
-
Mark
Decreased risk of ischemic heart disease in individuals with severe alpha 1-antitrypsin deficiency (PiZZ) in comparison with the general population
(
- Contribution to journal › Article
-
Mark
Chronic airflow limitation and its relation to respiratory symptoms among ever-smokers and never-smokers : a cross-sectional study
(
- Contribution to journal › Article
- 2019
-
Mark
Survival in the Swedish cohort with alpha-1-antitrypsin deficiency, up to the age of 43-45 years
(
- Contribution to journal › Article
-
Mark
Liver disease in adults with severe alpha-1-antitrypsin deficiency
(
- Contribution to journal › Article
-
Mark
The association of body mass index, weight gain and central obesity with activity-related breathlessness : The Swedish Cardiopulmonary Bioimage Study
(
- Contribution to journal › Article
-
Mark
Decline in FEV1 and hospitalized exacerbations in individuals with severe alpha-1 antitrypsin deficiency
(
- Contribution to journal › Article
- 2018
-
Mark
Lung function and CT lung densitometry in 37-to 39-year-old individuals with alpha-1-antitrypsin deficiency
(
- Contribution to journal › Article
- 2017
-
Mark
Burn injury during long-term oxygen therapy in Denmark and Sweden : The potential role of smoking
(
- Contribution to journal › Article
-
Mark
Lung transplantation and survival outcomes in patients with oxygen-dependent COPD with regard to their alpha-1 antitrypsin deficiency status
(
- Contribution to journal › Article
-
Mark
Health status and lung function in the Swedish alpha 1-antitrypsin deficient cohort, identified by neonatal screening, at the age of 37-40 years
(
- Contribution to journal › Article
-
Mark
Survival in individuals with severe alpha 1-antitrypsin deficiency (PiZZ) in comparison to a general population with known smoking habits
(
- Contribution to journal › Article
-
Mark
Risk of cancer after lung transplantation for COPD
(
- Contribution to journal › Article
-
Mark
Liver function in alpha-1-antitrypsin deficient individuals at 37 to 40 years of age
(
- Contribution to journal › Article
- 2016
-
Mark
Cause-specific mortality in individuals with severe alpha 1-antitrypsin deficiency in comparison with the general population in Sweden
(
- Contribution to journal › Article
- 2015
-
Mark
Lung Function and CT Densitometry in Subjects with alpha-1-Antitrypsin Deficiency and Healthy Controls at 35 Years of Age.
(
- Contribution to journal › Article
-
Mark
The Clinical Profile of Subjects Included in the Swedish National Register on Individuals with Severe Alpha 1-Antitrypsin deficiency.
(
- Contribution to journal › Article
-
Mark
The risk of burn injury during long-term oxygen therapy: a 17-year longitudinal national study in Sweden.
(
- Contribution to journal › Article
-
Mark
The Swedish Alpha 1-antitrypsin Screening Study: Health Status, Lung and Liver Function at Age 34.
2015) In Annals of the American Thoracic Society(
- Contribution to journal › Article
- 2014
-
Mark
Survival benefit of lung transplantation for chronic obstructive pulmonary disease in sweden.
(
- Contribution to journal › Article
- 2011
-
Mark
Clinical course and prognosis of individuals with severe alpha 1-antitrypsin deficiency (PiZZ)
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Survival benefit of lung transplantation in individuals with severe α(1)-anti-trypsin deficiency (PiZZ) and emphysema.
(
- Contribution to journal › Article
- 2010
-
Mark
Survival in severe alpha-1-antitrypsin deficiency (PiZZ)
(
- Contribution to journal › Article
- 2008
-
Mark
Clinical course and prognosis of never-smokers with severe alpha-1-antitrypsin deficiency (PiZZ).
(
- Contribution to journal › Article